PHARMA NORGE AS

8432 ALSVÅG

Finances

Return on Equity

33,26 %

Current Ratio

1,15

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	43 553 000	44 108 000	42 439 000	29 373 000
Net Income	10 244 000	10 584 000	11 717 000	6 335 000
Total Assets	40 396 000	13 334 000	11 329 000	5 581 000
Total Equity	30 804 000	5 068 000	2 701 000	1 384 000

Income (NOK)	2022	2021	2020	2019
Revenue	43 553 000	44 108 000	42 439 000	29 373 000
Expenditure	30 396 000	30 576 000	27 691 000	21 078 000
Operating Profit	13 157 000	13 660 000	14 901 000	8 109 000
Financial Income	30 000	24 000	143 000	14 000
Financial Costs	3 000	1 000	14 000	1 000
Financial Balance	27 000	23 000	129 000	13 000
Earnings Before Tax	13 184 000	13 683 000	15 030 000	8 122 000
Tax	2 941 000	3 099 000	3 312 000	1 787 000
Net Income	10 244 000	10 584 000	11 717 000	6 335 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	29 401 000	424 000	528 000	304 000
Total Current Assets	10 995 000	12 910 000	10 801 000	5 277 000
Total Assets	40 396 000	13 334 000	11 329 000	5 581 000
Total Retained Equity	7 729 000	4 786 000	2 408 000	1 091 000
Total Equity	30 804 000	5 068 000	2 701 000	1 384 000
Total Long-Term Debt	0	0	20 000	17 000
Total Current Debt	9 593 000	8 265 000	8 608 000	4 180 000
Total Equity and Debt	40 396 000	13 334 000	11 329 000	5 581 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	43 245 000	43 353 000	42 091 000	29 373 000
Other Income	308 000	755 000	348 000	0
Revenue	43 553 000	44 108 000	42 439 000	29 373 000
Cost of Goods Sold	6 465 000	7 918 000	4 333 000	2 990 000
Salary Costs	9 656 000	8 094 000	6 585 000	3 940 000
Depreciation	190 000	177 000	130 000	8 000
Impairment	0	0	0	0
Expenditure	30 396 000	30 576 000	27 691 000	21 078 000
Operating Profit	13 157 000	13 660 000	14 901 000	8 109 000
Financial Income	30 000	24 000	143 000	14 000
Financial Costs	3 000	1 000	14 000	1 000
Financial Balance	27 000	23 000	129 000	13 000
Dividends	9 500 000	6 100 000	10 400 000	5 300 000
Net Income	10 244 000	10 584 000	11 717 000	6 335 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	24 000	142 000	265 000	273 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	207 000	201 000	183 000	0
Total Tangible Assets	207 000	201 000	183 000	0
Total Fiancial Fixed Assets	29 169 000	80 000	80 000	31 000
Total Fixed Assets	29 401 000	424 000	528 000	304 000
Stock	1 620 000	1 239 000	159 000	5 000
Total Investments	0	2 125 000	0	25 000
Cash, Bank	6 264 000	6 533 000	8 178 000	1 070 000
Total Current Assets	10 995 000	12 910 000	10 801 000	5 277 000
Total Assets	40 396 000	13 334 000	11 329 000	5 581 000
Total Equity	30 804 000	5 068 000	2 701 000	1 384 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	20 000	17 000
Creditors	884 000	1 613 000	1 284 000	981 000
Unpaid Taxes	1 040 000	1 191 000	1 049 000	653 000
Dividends	9 500 000	6 100 000	10 400 000	5 300 000
Other Current Debt	2 728 000	2 342 000	1 165 000	775 000
Total Current Debt	9 593 000	8 265 000	8 608 000	4 180 000
Total Equity and Debt	40 396 000	13 334 000	11 329 000	5 581 000

Financial indicators	2022	2021	2020	2019
Return on Equity	33,26 %	208,84 %	433,8 %	457,73 %
Debt-to-Equity Ratio	0	0	0,01	0,01
Operating Profit Margin	30,21 %	30,97 %	35,11 %	27,61 %
Current Ratio	1,15	1,56	1,25	1,26
Quick Ratio	1,38	1,84	1,28	1,26
Equity Ratio	0,76	0,38	0,24	0,25
Gross Profit Margin	85,16 %	82,05 %	89,79 %	89,82 %